Drugs Made IN America Acquisition Corp. Rights (DMAAR)
Drugs Made IN America Acquisition Corp. Rights (DMAAR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | DMAAR | ||||
| Company | Drugs Made IN America Acquisition Corp. Rights | ||||
| Price Information | |||||
| Exchange | NASDAQ | ||||
| Open | 0.0904 | ||||
| High | 0.0989 | ||||
| Low | 0.0904 | ||||
| Latest | 0.0989 | ||||
| Change | +0.0094 | ||||
| % Change | +10.50% | ||||
| Volume | 1,169 | ||||
| 20-Day Average Volume | 108,493 | ||||
| Previous Close | 0.0895 | ||||
| Industry | N/A | ||||
| Has Options | No | ||||
| Technicals | |||||
| 20-Day Moving Average | 0.0831 | ||||
| 20-Day Raw Stochastic | 87.09% | ||||
| 20-Day Relative Strength | 57.00 | ||||
| Weighted Alpha | -45.33 | ||||
| Today's Opinion | 40% Sell | ||||
| Previous Opinion | 40% Sell | ||||
| Last Month's Opinion | 88% Sell | ||||
| Performance | |||||
| 5-Days | |||||
| %Chg | +16.35% since 04/24/26 | ||||
| Low | 0.0752 on 04/27/26 | ||||
| High | 0.0990 on 04/30/26 | ||||
| 1-Month | |||||
| %Chg | +64.83% since 04/01/26 | ||||
| Low | 0.0510 on 04/02/26 | ||||
| High | 0.1060 on 04/08/26 | ||||
| 3-Month | |||||
| %Chg | -28.70% since 01/30/26 | ||||
| Low | 0.0400 on 03/24/26 | ||||
| High | 0.1400 on 02/23/26 | ||||
| 6-Month | |||||
| %Chg | -43.32% since 10/31/25 | ||||
| Low | 0.0400 on 03/24/26 | ||||
| High | 0.2100 on 11/24/25 | ||||
| Key Statistics | |||||
| Market Capitalization, $K | N/A | ||||
| Shares Outstanding, K | N/A | ||||
| Annual Sales | 0 | ||||
| Annual Net Income | 0 | ||||
| Last Quarter Sales | N/A | ||||
| Last Quarter Net Income | N/A | ||||
| 60-Month Beta | N/A | ||||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | ||||
| Earnings Date | N/A | ||||
| Most Recent Dividend | N/A | ||||
| Next Ex-Dividends Date | N/A | ||||
| Ratios | |||||
| Price/Earnings ttm | N/A | ||||